v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The following two tables summarize our total stock-based compensation expense by award type and where the stock-based compensation expense was recorded in our condensed consolidated statements of operations (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
(unaudited)(unaudited)
Restricted stock units$2,527 $5,928 $5,910 $11,453 
Performance-based restricted stock units9 2,048 186 3,213 
Employee stock purchase plan72 245 183 529 
Restricted shares101 102 200 671 
Options— — — — 
Total stock-based compensation$2,709 $8,323 $6,479 $15,866 
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
(unaudited)(unaudited)
Cost of revenue$417 $1,489 $1,084 $2,710 
Sales and marketing613 2,542 1,409 4,704 
Research and development366 1,316 956 2,449 
General and administrative1,313 2,976 3,030 6,003 
Total stock-based compensation$2,709 $8,323 $6,479 $15,866 
Schedule of Information Related to Stock Options A summary of the share option activity under the 2019 Plan for the six months ended June 30, 2026, is as follows:
Time-Based Option SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value
(unaudited)
Outstanding at January 1, 2026
842,085 $12.36 
Options cancelled/expired
(139,144)11.54 
Outstanding at June 30, 2026
702,941 $12.53 2.1$— 
Vested and exercisable as of June 30, 2026
702,941 $12.53 2.1$— 
Schedule of Outstanding RSUs and Related Activity The following table sets forth the outstanding RSUs and related activity for the six months ended June 30, 2026:
Restricted Stock UnitsWeighted Average Grant Date Fair Value
(unaudited)
Unvested and outstanding at January 1, 2026
4,004,505 $5.72 
RSUs granted2,711,887 1.68 
RSUs vested(1,494,916)4.85 
RSUs forfeited(793,780)5.37 
Unvested and outstanding at June 30, 2026
4,427,696 $3.61 
The following table sets forth the outstanding PRSUs, including executive PRSUs with market-based tranches, and related activity for the six months ended June 30, 2026:
Performance-based Restricted Stock UnitsWeighted Average Grant Date Fair Value
(unaudited)
Unvested and outstanding at January 1, 2026
2,521,754 $5.40 
PRSUs granted59,053 1.77 
PRSUs vested(863,096)5.18 
PRSUs forfeited(1,416,209)5.59 
Unvested and outstanding at June 30, 2026
301,502 $4.37 
Schedule of Fair Value Measurement Inputs and Valuation Techniques The fair value of the market-based tranches included in the executive PRSUs were estimated on the date of grants using the Monte Carlo simulation valuation model with the following assumptions for the six months ended June 30, 2025:
Six Months Ended
June 30, 2025
Expected volatility71.6%
Expected term (in years)
1-3
Risk-free interest rate
4.16% - 4.23%
Expected dividends—
Schedule of Employee Stock Purchase Plan
The fair value of the purchase right for the ESPP option component is estimated on the date of grant using the Black-Scholes model with the following assumptions for the six months ended June 30, 2026 and 2025:
Six Months Ended June 30,
20262025
(unaudited)
Expected volatility
73.9%
75.2%
Expected term (in months)66
Risk-free interest rate
3.58%
4.25%
Expected dividends——